Precedent Wealth Partners LLC Purchases 1,881 Shares of The Clorox Company $CLX

Precedent Wealth Partners LLC boosted its position in shares of The Clorox Company (NYSE:CLX) by 20.0% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 11,303 shares of the company’s stock after buying an additional 1,881 shares during the quarter. Precedent Wealth Partners LLC’s holdings in Clorox were worth $1,357,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. American National Bank & Trust raised its holdings in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after buying an additional 89 shares during the last quarter. Ransom Advisory Ltd purchased a new position in Clorox during the 1st quarter valued at $35,000. GW&K Investment Management LLC increased its position in Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after purchasing an additional 208 shares during the period. Roble Belko & Company Inc increased its position in Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock valued at $53,000 after purchasing an additional 211 shares during the period. Finally, IMA Advisory Services Inc. purchased a new position in Clorox during the 1st quarter valued at $58,000. 78.53% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of research analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Clorox in a research report on Saturday, September 27th. Barclays reduced their price objective on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday. The Goldman Sachs Group reduced their price objective on shares of Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday. Wells Fargo & Company reduced their price objective on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating on the stock in a research report on Thursday, September 25th. Finally, Jefferies Financial Group reduced their price objective on shares of Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research report on Thursday, June 26th. One analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and a consensus price target of $134.08.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.57% of the stock is currently owned by insiders.

Clorox Stock Up 0.9%

NYSE:CLX opened at $123.30 on Friday. The firm’s 50-day moving average price is $122.81 and its 200-day moving average price is $129.64. The company has a market capitalization of $15.08 billion, a PE ratio of 18.91, a P/E/G ratio of 0.98 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The Clorox Company has a 1-year low of $116.53 and a 1-year high of $171.37.

Clorox (NYSE:CLX) last released its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. The firm had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company’s revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a $1.24 dividend. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. Clorox’s payout ratio is presently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.